Hepatorenal syndrome (HRS) represents an acute complication of decompensated cirrhosis and is a subtype of acute kidney injury (AKI), with high associated mortality. This activity consists of 6 paired conversations with experts from Europe and the United States in the fields of hepatology, critical care, nephrology, and transplantation. During these paired conversations, the faculty explore revised diagnostic criteria, emerging treatment, and coordinating effective multidisciplinary care. In addition, the faculty panel collaboratively reviews a patient case where they share international perspectives on the nonpharmacological and pharmacological treatment of patients with HRS-AKI.
This program is also available as a podcast. You may download it here: https://anchor.fm/hrs-aki
Course Credit:
1.75 ACPE Contact Hours
1.75 AMA PRA Category 1 CreditsTM
1.75 ANCC Contact Hours
Dates:
Opens: 2022-08-15
Closes: 2023-08-15
Target Audience:
This activity is intended for a national audience of critical care physicians, hepatologists, nephrologists, transplant surgeons, critical care pharmacists, nurse practitioners, physician assistants, and other clinicians who care for patients with hepatorenal syndrome-acute kidney injury (HRS-AKI).
This activity is supported by an educational grant from Mallinckrodt.
-
Paolo Angeli, MD, PhD
Unit of Hepatic Emergencies and Liver Transplantation
University of Padova
Padova, Italy -
Amanda Chaney, DNP, APRN
Senior Director of Advanced Practice Services
Cleveland Clinic
Florida Region
Weston, Florida -
Kevin Moore, MB.BS, PhD
Institute of Liver and Digestive Health
University College
London, United Kingdom -
Mitra K. Nadim, MD
Director, USC Hypertension Center
Keck Medicine of USC
Los Angeles, California -
Rahul Nanchal, MD
Division of Pulmonary and Critical Care Medicine
Medical College of Wisconsin
Milwaukee, Wisconsin -
Ram Subramanian, MD, MBA
Director of Liver Critical Care Services
Emory University School of Medicine
Atlanta, Georgia
